Cargando…
Eculizumab treatment for renal failure in a pediatric patient with COVID-19
While there are increasing reports of acute kidney injury among hospitalized adults with COVID-19, there is still limited information on renal complications associated with COVID-19 in children. The cause of kidney involvement in COVID-19 is likely multifactorial, and appears to involve a complex pr...
Autores principales: | Mahajan, Ruchi, Lipton, Marissa, Broglie, Larisa, Jain, Namrata Gargee, Uy, Natalie Somera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519698/ https://www.ncbi.nlm.nih.gov/pubmed/32981025 http://dx.doi.org/10.1007/s40620-020-00858-2 |
Ejemplares similares
-
Role of pediatric nephrologists in managing adults with AKI due to COVID-19
por: Lipton, Marissa, et al.
Publicado: (2020) -
COVID-19 and acute kidney injury in pediatric subjects: is there a place for eculizumab treatment?
por: Trimarchi, Hernán, et al.
Publicado: (2020) -
Eculizumab: COVID-19: case report
Publicado: (2021) -
Complement activation and effect of eculizumab in scleroderma renal crisis
por: Devresse, Arnaud, et al.
Publicado: (2016) -
Scleroderma Renal Crisis With Thrombotic Microangiopathy Treated With Eculizumab
por: Saba, Ludovic, et al.
Publicado: (2022)